Company: PTHS
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001753926-25-001764
Chunk: 33

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 1
Chunk 33
---
 — 

    Commercial data platforms 
     152  
     — 

    Patient assistance platforms 
     113  
     — 

    Financial reporting platforms 
     80  
     — 

    Deferred offering costs 
     711  
     750 

    Other 
     574  
     106 

    Total prepaid expenses and other current assets 
    $3,424  
    $856 

Inventory
consisted of the following:

    September 30, 2025  
    December 31, 2024 

    Raw materials 
    $605  
    $— 

    Work-in-process 
     17,029  
     — 

    Finished goods 
     6,462  
     — 

    Total inventory 
    $24,096  
    $— 

Property
and equipment consisted of the following:

    September 30, 2025  
    December 31, 2024 

    Manufacturing and laboratory equipment 
    $1,745  
    $— 

    Software 
     1,083  
     — 

    Furniture and fixtures 
     69  
     — 

    Leasehold improvements 
     5,930  
     — 

    Construction-in-progress 
     1,735  
     — 

    Property and equipment, cost 
     10,563  
     — 

    Less: Accumulated depreciation and amortization 
     (389) 
     — 

    Total property and equipment, net 
    $10,174  
    $— 

The
Company’s depreciation expense was $389 for the three and nine months ended September 30, 2025.

    22

Goodwill
and other identifiable intangible assets consisted of the following:

    September 30, 2025  
    December 31, 2024 

    Indefinite-lived intangible assets 

    Goodwill 
    $30,625  
    $— 

    Definite-lived intangible assets 

    Developed technology 
     32,200  
     — 

    Sato license 
     1,000  
     — 

    Less: accumulated amortization 
     (679) 
     — 

    Total definite-lived